Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes. [electronic resource] by
- Delfino, D V
- Spinicelli, S
- Pozzesi, N
- Pierangeli, S
- Velardi, E
- Bruscoli, S
- Martelli, M P
- Pettirossi, V
- Falchi, L
- Kang, T-b
- Riccardi, C
Producer: 20110414
In:
Cell death and differentiation vol. 18
Availability: No items available.
|
|
13.
|
|
|
14.
|
MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET. [electronic resource] by
- Li, Y-Q
- Ren, X-Y
- He, Q-M
- Xu, Y-F
- Tang, X-R
- Sun, Y
- Zeng, M-S
- Kang, T-B
- Liu, N
- Ma, J
Producer: 20150911
In:
Cell death & disease vol. 6
Availability: No items available.
|
|
15.
|
Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells. [electronic resource] by
- Yoon, T J
- Yoo, Y C
- Kang, T B
- Shimazaki, K
- Song, S K
- Lee, K H
- Kim, S H
- Park, C H
- Azuma, I
- Kim, J B
Producer: 19990429
In:
Cancer letters vol. 136
Availability: No items available.
|
|
16.
|
Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy. [electronic resource] by
- Mao, Y-P
- Zhou, G-Q
- Liu, L-Z
- Guo, R
- Sun, Y
- Li, L
- Lin, A-H
- Zeng, M-S
- Kang, T-B
- Jia, W-H
- Shao, J-Y
- Mai, H-Q
- Ma, J
Producer: 20140714
In:
British journal of cancer vol. 110
Availability: No items available.
|
|
17.
|
Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer. [electronic resource] by
- Ju, H-Q
- Lu, Y-X
- Wu, Q-N
- Liu, J
- Zeng, Z-L
- Mo, H-Y
- Chen, Y
- Tian, T
- Wang, Y
- Kang, T-B
- Xie, D
- Zeng, M-S
- Huang, P
- Xu, R-H
Producer: 20171201
In:
Oncogene vol. 36
Availability: No items available.
|
|
18.
|
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma. [electronic resource] by
- Nairismägi, M -L
- Gerritsen, M E
- Li, Z M
- Wijaya, G C
- Chia, B K H
- Laurensia, Y
- Lim, J Q
- Yeoh, K W
- Yao, X S
- Pang, W L
- Bisconte, A
- Hill, R J
- Bradshaw, J M
- Huang, D
- Song, T L L
- Ng, C C Y
- Rajasegaran, V
- Tang, T
- Tang, Q Q
- Xia, X J
- Kang, T B
- Teh, B T
- Lim, S T
- Ong, C K
- Tan, J
Producer: 20190315
In:
Leukemia vol. 32
Availability: No items available.
|